Lab Result

Your OTP (One time password) received you your registered mobile number.
For Reg. No. & OPD/IPD/EM No., please refer to the respective Bill Receipt.

Request a Callback

Dr. Rashmi Rana

Consultant

Department of Biotechnology and Research

Book Direct Appt. Book Video Appt.
Dr. Rashmi Rana

Dr. Rashmi Rana

Dr. Rashmi Rana is a distinguished researcher and academic at Sir Ganga Ram Hospital, New Delhi, where she has been part of the Department of Biotechnology and Research since August 1, 2017. She is also an Associate Professor at GRIPMER and coordinates the MAHE PhD program and PG Diploma in Clinical Research. Dr. Rana holds a PhD and has postdoctoral training in Clinical Biochemistry and Biophysics with a focus on Multi-omics approaches.

Her research primarily focuses on oncology, particularly gliomas and brain tumors like meningioma’s. Dr. Rana's ground-breaking work includes identifying LGALS3BP as a non-invasive biomarker for monitoring glioma progression. She is currently developing innovative treatment strategies for gliomas, such as silencing LGALS3BP to inhibit tumor growth and using CRISPR gene editing to correct mutated genes. Additionally, she is exploring methods to cross the blood-brain barrier for targeted chemotherapy delivery, enhancing treatment efficacy while minimizing side effects.

Dr. Rana also applies her expertise in proteomics to infectious diseases like Dengue and Sepsis, focusing on their impact on kidney function, as well as investigating Chronic Kidney Disease (CKD) and graft rejection prediction. Dr. Rana’s contributions to science have earned her numerous prestigious awards, including the ESMO, HUPO, and EMBO fellowships, the Bill & Melinda Gates Fellowship in 2023, the HCFI Dr. K. K. Aggarwal Research Innovation Fund Award, the DST Young Scientist Award, the INYAS Fellowship, and member in organizations such as NAMS (Vector Borne Disease) and DNDi WHO, among others. Dr. Rana is selected for the EMBO Lab Leadership Program.

Dr. Rana is invited as speaker by the renowned organizations such as DRDO, DU, AIIMS, IITs etc. She is invited as a PhD examiner at Karolinska Institute, Sweden and KGMC Lucknow. She is the Convener of Proteomic Society of India. She is the member of the National and International societies. Dr. Rana is guiding 5 PhD students under her guidance.

Recently She established a Multi-Omics Core Facility in SGRH, Delhi.

Dr. Rana mentors a team of scientists, doctoral, and graduate students while leading five ongoing research projects. Her work continues to advance cancer research, Diagnostic and therapeutic innovations, and novel Multi-omics approaches. She is also an editor for several respected scientific journals, shaping the future of medical research.

Publications

1. Rana R*, Devi SN, Bhardwaj AK, Yashavarddhan MH, Bohra D, Ganguly NK. Exosomes as nature's nano carriers: Promising drug delivery tools and targeted therapy for glioma. Biomedicine & Pharmacotherapy. 2025 Jan 1; 182:117754.

2. Sharma N, Bhat SH, Mathew B, Yadav M, Tripathi G, Bindal V, Yadav S, Sharma N, Pandey S, Hemati H, Bohra D, Rana R*. Bile molecular landscape provides pathological insight and classifies signatures predictive of carcinoma of the gall bladder. Molecular Therapy Oncology. 2024 Dec 19;32(4).

3. Sharma S, Shamjetsabam ND, Chauhan K, Yashavarddhan MH, Gautam P, Prakash P, Choudhary P, Chhabra SS, Acharya R, Kalra SK, Gupta A, Rana R*. Quantitative tissue analysis reveals AK2, COL1A1, and PLG protein signatures: targeted therapeutics for meningioma. International Journal of Surgery. 2024 Dec 1;110(12):7434-46.

4. Chauhan K, Vijayan V, Pant P, Sharma S, Hassan MI, Ganguly NK, Sharma P, Rana R*. Identifying potential inhibitors against galectin-3-binding protein (LGALS3BP) for therapeutic targeting of glioma. Journal of Biomolecular Structure and Dynamics. 2024 Nov 17:1-3.

5. Shamjetsabam ND, Rana R*, Malik P, Ganguly NK. CRISPR/Cas9: an overview of recent developments and applications in cancer research. International Journal of Surgery. 2024 Oct 1;110(10):6198-213.

View all: https://scholar.google.com/citations?hl=en&user=p1jlXfIAAAAJ

Patent

Method for early detection and diagnosis of brain tumor, Rashmi Rana, Kirti Chauhan, Poonam Gautam, Mahesh Kulkarni, Reema Banerjee, Satnam Singh Chhabra, Rajesh Acharya, Samir Kumar Kalra, Anshul Gupta, Sunila Jain, Nirmal Kumar Ganguly. Application No: 202111019222 Year 2021.

Funding’s

Indian Council of Medical Research (ICMR), Govt of India

Defence Research and Development Organization (DRDO), Govt of India

Department of Health Research (DHR), ICMR, Govt of India

Research and Development Programme, Sir Ganga Ram hospital

Invited Speaker:

Delhi University

All India Institute of Medical Sciences

IIT, Bombay

IIT, Delhi

DIPAS, DRDO

Languages Spoken:
Education: MSc - Delhi University, Delhi (2005) | Ph.D Biochemistry - NIOP (ICMR) affiliated to GGSIP University, Delhi (2012)

Book Appointment
Positions Held
  • National Institute of Pathology (ICMR), Delhi
    Junior Research Fellowship (JRF)
    2007 - 2009
  • National Institute of Pathology (ICMR), Delhi
    Senior Research Fellowship (SRF)
    2013 - 2018
  • All India Institute of Medical Sciences (AIIMS), Delhi
    Postdoctoral Fellow
    2013 - 2017
  • Defence Institute of Physiology and Allied Sciences (DRDO), Delhi
    Research Associate
    2016 - 2017
  • Sir Ganga Ram Hospital (SGRH), Delhi
    Consultant
    2017 - 2025
Professional memberships
  • European Society of Molecular Oncology - ESMO
  • European Molecular Biology Organization - EMBO
  • Proteomics Society of India - PSI
  • Indian Society of Translational Research - ISTR
  • Indian Society of Electron Microscopy - EMSI
  • American Society and Gene and Cell Therapy - ASGCT
  • World Environmental
  • International Society of Toxicology - SOT
  • International Society of Exposure Sciences and Toxicology - ISES
  • Indian Society of Andrology - ISA
  • Indian Society for the Study of Reproduction
  • International Society of Proteomics - ISP
  • Metabolic Syndrome, Pre-diabetes and PCOS Society
Training and Certifications
  • EMBO Leadership Programme
    2024 - 2024
  • Participated in Festival on Innovation and Research in Science and Technology
    2023 - 2023
  • Participation on CRISPR and the Clinic-So Near and Yet So Far. In National Academy of Medical Sciences
    2023 - 2023
  • Attended the training course on MS community Meet (LCMS/MS Basics Software operation
    2023 - 2023
  • Foundations Clinical Research Program, Harvard Medical School, USA
    2021 - 2021
  • EMBO Practical Courses: Targeted Proteomics – Experimental Design and Data Analysis on 10th –15th November 2019, organized by the CRG (Centre for Genomic Regulation) in Barcelona, Spain
    2019 - 2019
  • EMBO fellowship to attend the EMBO course and Computational analysis of protein-protein interactions: Sequences, networks and diseases and taking place in Rome, Italy from 05-20 November 2018
    2018 - 2018
Interests
Proteomics, Nanomedicine, Stem Cell Research
Awards